Clinical Trial

Efficacy and Safety of Combo-stim Deep Brain Stimulation for Treatment-refractory Mental Disorders

Recruiting
View on ClinicalTrials.gov →
Summary
This is a multi-center, single arm, prospective, open-label, extendable study for the efficacy and safety of combo-stim deep brain stimulation for treatment-refractory mental disorders (obsessive-compulsive disorder, schizophrenia, bipolar with depression, anorexia nervosa, gambling disorder and adult autism).
Protocol Amendment History 2 amendments
This ClinicalTrials.gov record has been amended 2 times since 2023-10-26; most recent amendment 2025-05-14.
Trial Details
NCT Number NCT06112067
Lead Sponsor Shanghai Mental Health Center
Collaborators: SceneRay Corporation, Limited, Huashan Hospital, Shanghai 6th People's Hospital, Changhai Hospital
Conditions Deep Brain Stimulation
Enrollment 18 participants
Start Date 2023-10-16
Primary Completion 2026-08 (estimated)
Study Completion 2026-08 (estimated)
Updated on ClinicalTrials.gov 2025-05-18